Susquehanna International Group
SPRB

Susquehanna International Group’s Spruce Biosciences SPRB Stock Holding History

Susquehanna International Group’s Portfolio SPRB Stock Details SPRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-786
Closed -$24.8K – 13705
2024
Q4 		$24.8K Buy
+786
New +$28.8K ﹤0.01% 11881
2024
Q2 		– Sell
-396
Closed -$21.2K – 13434
2024
Q1 		$23.3K Buy
+396
New +$101K ﹤0.01% 11782
2022
Q1 		– Sell
-364
Closed -$122K – 14158
2021
Q4 		$122K Buy
+364
New +$108K ﹤0.01% 11994

Other funds holding SPRB

CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Susquehanna International Group's SPRB Position: Q1 2025 in Review

Susquehanna International Group sold out of Spruce Biosciences (SPRB) in Q1 2025, closing a stake of 786 shares — an estimated $24.8K sold.

Susquehanna International Group first reported a position in SPRB in Q4 2021 and held it in 3 quarters. The position peaked at $122K in Q4 2021. 31 funds tracked by Wall St. Rank hold SPRB as of Q1 2025.

  • Susquehanna International Group reported no remaining Spruce Biosciences position as of Q1 2025 after selling out during the quarter.
  • Susquehanna International Group sold 786 Spruce Biosciences shares in Q1 2025, an estimated $24.8K.
  • Susquehanna International Group first reported a position in Spruce Biosciences in Q4 2021 and held it in 3 quarters.
  • Susquehanna International Group's Spruce Biosciences position peaked at $122K in Q4 2021.
  • 31 funds tracked by Wall St. Rank held Spruce Biosciences as of Q1 2025.

Based on Susquehanna International Group's 13F filing for Q1 2025, filed 14 May 2025.